Search Within

Gastrointestinal Oncology Service

  1. "Cancer Immunology Research"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (2)
Groups
  1. Department of Medicine (6)
  2. Solid Tumor Oncology Division (6)
  3. Center for Hematologic Malignancies (2)
  4. Center for Pancreatic Cancer Research (2)
  5. Department of Pathology and Laboratory Medicine (2)
  6. GSK Faculty (2)

More Groups

People
  1. Neil Segal (3)
  2. Luis Diaz (2)
  3. Alexander Lesokhin (1)
  4. Alyona Weinstein (1)
  5. Andrew Weinstein (1)
  6. Anna Skripnik (1)

More People

Years
  1. 2025 (1)
  2. 2020 (1)
  3. 2019 (1)
  4. 2017 (1)
  5. 2016 (2)
Publications
  1. Cancer Immunology Research (6)
Publishers
  1. American Association for Cancer Research (6)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Host tissue factors predict immune surveillance and therapeutic outcomes in gastric cancer
    Journal Article

    Abate, M.; Stroobant, E. E.; Fei, T.; Lin, Y. H.; Shimada, S.; Drebin, H.; Chen, E.; Tang, L. H.; Shah, S. P.; Wolchok, J. D.; more...
    Cancer Immunology Research (2025)

    Fulltext@MSK | Save
  • Tumor-intrinsic drivers of response and resistance to checkpoint blockade in MRD tumors
    Meeting Abstract

    Diaz, L. A.
    Cancer Immunology Research (2020)

    Fulltext@MSK | Save
  • Immunopathologic stratification of colorectal cancer for checkpoint blockade immunotherapy
    Journal Article

    Llosa, N. J.; Luber, B.; Siegel, N.; Awan, A. H.; Oke, T.; Zhu, Q.; Bartlett, B. R.; Aulakh, L. K.; Thompson, E. D.; Jaffee, E. M.; more...
    Cancer Immunology Research (2019)

    Fulltext@MSK | Save
  • A blueprint to advance colorectal cancer immunotherapies
    Journal Article

    Le, D. T.; Hubbard-Lucey, V. M.; Morse, M. A.; Heery, C. R.; Dwyer, A.; Marsilje, T. H.; Brodsky, A. N.; Chan, E.; Deming, D. A.; Diaz, L. A. Jr; more...
    Cancer Immunology Research (2017)

    Fulltext@MSK | Save
  • Autoimmune bullous skin disorders with immune checkpoint inhibitors targeting PD-1 and PD-L1
    Journal Article

    Naidoo, J.; Schindler, K.; Querfeld, C.; Busam, K.; Cunningham, J.; Page, D. B.; Postow, M. A.; Weinstein, A.; Lucas, A. S.; Ciccolini, K. T.; more...
    Cancer Immunology Research (2016)

    Fulltext@MSK | Save
  • Safety and clinical activity of durvalumab (MEDI4736), an anti-programmed cell death ligand-1 (PD-L1) antibody, in patients with non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Antonia, S.; Rizvi, N.; Brahmer, J.; Ou, S. H.; Khleif, S. N.; Hwu, W. J.; Gutierrez, M.; Schoffski, P.; Hamid, O.; Weiss, J.; more...
    Cancer Immunology Research (2016)

    Fulltext@MSK | Save